COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL, CAR-T) FOR THE TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN GREECE

被引：0
|
作者：
Loupas, M. A. [1 ]
Theodoratou, D. [2 ]
Kourlaba, G. [1 ]
机构：
[1] Econcare LP, Athens A1, Greece
[2] Gilead Sci Hellas, Palaio Faliro, Greece
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE298
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma
    Marchetti, M.
    Visco, C.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1442 - 1450
  • [2] Assessment of durable responses after brexucabtagene autoleucel (brexu-cel) in relapsed/refractory mantle cell lymphoma (R/R MCL)
    Pindoria, Lohit
    Munoz, Javier
    Reagan, Patrick
    Goy, Andre
    Miklos, David
    Zheng, Dan
    Fang, Xiang
    Shen, Rhine
    Siddiqi, Rubina
    Kloos, Ioana
    Kersten, Marie Jose
    Wang, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 113 - 114
  • [3] COST-EFFECTIVENESS OF THE BREXU-CEL IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A SYSTEMATIC REVIEW
    Khatiwada, A.
    Kamel, A.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2024, 27 (06) : S80 - S80
  • [4] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [5] Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review
    Khatiwada, Asmita Priyadarshini
    Kamel, Ahmed Mostafa Ahmed
    Chaiyakunapruk, Nathorn
    Ngorsuraches, Surachat
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (03) : 323 - 335
  • [6] Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory (R/R) mantle cell lymphoma (MCL): A CIBMTR subgroup analysis by prior treatment.
    Kambhampati, Swetha
    Ahmed, Nausheen
    Hamadani, Mehdi
    Grover, Natalie Sophia
    Shadman, Mazyar
    Locke, Frederick L.
    Gerson, James M.
    Frank, Matthew Joshua
    Budde, Lihua Elizabeth
    Wang, Michael
    Hu, Zhen-Huan
    Nunes, Ana
    Dalton, David
    Kloos, Ioana
    Lee, Daniel
    Xu, Hairong
    Pasquini, Marcelo C.
    Herrera, Alex Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] COST-EFFECTIVENESS ANALYSIS OF AXICABTAGENE CILOLEUCEL, BREXUCABTAGENE AUTOLEUCEL, AND STANDARD OF CARE FOR TREATMENT OF RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA
    Ghanem, B.
    Brown, L.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S375 - S375
  • [8] Outpatient Administration of Brexucabtagene Autoleucel (brexu-cel) for Acute Lymphoblastic Leukemia (ALL) and Mantle Cell Lymphoma (MCL) Is Safe and Feasible
    Othman, Tamer
    Baird, John H.
    Wang, Yan
    Pak, Stacy
    Aldoss, Ibrahim
    Cai, Ji-Lian
    Danilov, Alexey
    Phillips, Tycel J.
    Agrawal, Uaibhav
    Sandhu, Karamjeet S.
    Mei, Matthew
    Koller, Paul B.
    Palmer, Joycelynne Michelle
    Forman, Stephen J.
    Budde, Lihua E.
    Aribi, Ahmed
    BLOOD, 2024, 144 : 2278 - 2279
  • [9] Real-World Outcomes of Brexucabtagene Autoleucel ( Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics
    Kambhampati, Swetha
    Ahmed, Nausheen
    Hamadani, Mehdi
    Kim, Soyoung
    Hemmer, Michael T.
    Grover, Natalie S.
    Shadman, Mazyar
    Beitinjaneh, Amer
    Budde, L. Elizabeth
    Gerson, James
    Jacobson, Caron A.
    Locke, Frederick L.
    Nasta, Dwivedy S.
    Wang, Michael L.
    Weng, Wen-Kai
    Yan, Jiali
    Nunes, Ana
    Dalton, David
    Wu, James J.
    Abdeldaim, Amina
    Hu, Zhen-Huan
    Pasquini, Marcelo
    Herrera, Alex F.
    BLOOD, 2023, 142
  • [10] Real-world experience with CAR-T therapy with Brexucabtagene Autoleucel for advanced relapsed mantle cell lymphoma
    Heini, A.
    Kronig, M. -N.
    Bacher, U.
    Taleghani, B. Mansouri
    Novak, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 2 - 2
12345